NZ599215A - Compounds for treating disorders or diseases associated with neurokinin 2 receptor activity - Google Patents
Compounds for treating disorders or diseases associated with neurokinin 2 receptor activityInfo
- Publication number
- NZ599215A NZ599215A NZ599215A NZ59921510A NZ599215A NZ 599215 A NZ599215 A NZ 599215A NZ 599215 A NZ599215 A NZ 599215A NZ 59921510 A NZ59921510 A NZ 59921510A NZ 599215 A NZ599215 A NZ 599215A
- Authority
- NZ
- New Zealand
- Prior art keywords
- compounds
- neurokinin
- diseases associated
- receptor activity
- treating disorders
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 2
- 108010040722 Neurokinin-2 Receptors Proteins 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000035475 disorder Diseases 0.000 title 1
- WGBCSEJHHMTXMJ-UHFFFAOYSA-N 6-MMAM Natural products CCCCCCCCC(C)CCCCC(=O)OCC(O)CO WGBCSEJHHMTXMJ-UHFFFAOYSA-N 0.000 abstract 1
- 208000019901 Anxiety disease Diseases 0.000 abstract 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 abstract 1
- 208000019022 Mood disease Diseases 0.000 abstract 1
- 206010046543 Urinary incontinence Diseases 0.000 abstract 1
- 230000003001 depressive effect Effects 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
- 208000002551 irritable bowel syndrome Diseases 0.000 abstract 1
- -1 monoglyceride derivative compounds Chemical class 0.000 abstract 1
- 208000023504 respiratory system disease Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/02—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
- C07C69/22—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety
- C07C69/30—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety esterified with trihydroxylic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/003—Esters of saturated alcohols having the esterified hydroxy group bound to an acyclic carbon atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Pulmonology (AREA)
- Obesity (AREA)
- Addiction (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Reproductive Health (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24001409P | 2009-09-04 | 2009-09-04 | |
| PCT/US2010/048006 WO2011029099A1 (en) | 2009-09-04 | 2010-09-07 | Compounds for treating disorders or diseases associated with neurokinin 2 receptor activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ599215A true NZ599215A (en) | 2014-11-28 |
Family
ID=43649685
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ599215A NZ599215A (en) | 2009-09-04 | 2010-09-07 | Compounds for treating disorders or diseases associated with neurokinin 2 receptor activity |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20120190743A1 (enExample) |
| EP (1) | EP2473038A4 (enExample) |
| JP (1) | JP2013503908A (enExample) |
| KR (1) | KR20120081120A (enExample) |
| CN (1) | CN102740693A (enExample) |
| AU (1) | AU2010289276A1 (enExample) |
| BR (1) | BR112012004988A2 (enExample) |
| CA (1) | CA2773035A1 (enExample) |
| MX (1) | MX2012002551A (enExample) |
| NZ (1) | NZ599215A (enExample) |
| RU (1) | RU2012112943A (enExample) |
| SG (1) | SG178964A1 (enExample) |
| WO (1) | WO2011029099A1 (enExample) |
| ZA (1) | ZA201202492B (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2508180A1 (en) * | 2011-04-04 | 2012-10-10 | Nestec S.A. | Sn-1(3) Monoacylglycerides and lipid absorption |
| CA2918245C (en) | 2013-08-01 | 2022-08-30 | Dignify Therapeutics, Inc. | Compositions and methods for inducing urinary voiding and defecation |
| GB201315846D0 (en) | 2013-09-05 | 2013-10-23 | Imp Innovations Ltd | Method for treating or preventing hot flushes |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1001A (en) * | 1838-11-09 | Open grate fobj burning coai | ||
| GB820954A (en) * | 1956-05-02 | 1959-09-30 | Beecham Res Lab | Improvements in or relating to esters of 2,3-dimercaptopropanol |
| US3536809A (en) | 1969-02-17 | 1970-10-27 | Alza Corp | Medication method |
| US3598123A (en) | 1969-04-01 | 1971-08-10 | Alza Corp | Bandage for administering drugs |
| US3845770A (en) | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
| US3916899A (en) | 1973-04-25 | 1975-11-04 | Alza Corp | Osmotic dispensing device with maximum and minimum sizes for the passageway |
| JPS505309A (enExample) * | 1973-05-28 | 1975-01-21 | ||
| US4008719A (en) | 1976-02-02 | 1977-02-22 | Alza Corporation | Osmotic system having laminar arrangement for programming delivery of active agent |
| IE58110B1 (en) | 1984-10-30 | 1993-07-14 | Elan Corp Plc | Controlled release powder and process for its preparation |
| US5073543A (en) | 1988-07-21 | 1991-12-17 | G. D. Searle & Co. | Controlled release formulations of trophic factors in ganglioside-lipsome vehicle |
| JPH02131418A (ja) * | 1988-11-10 | 1990-05-21 | Sansho Seiyaku Co Ltd | 外用剤 |
| IT1229203B (it) | 1989-03-22 | 1991-07-25 | Bioresearch Spa | Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative. |
| US5120548A (en) | 1989-11-07 | 1992-06-09 | Merck & Co., Inc. | Swelling modulated polymeric drug delivery device |
| US5733566A (en) | 1990-05-15 | 1998-03-31 | Alkermes Controlled Therapeutics Inc. Ii | Controlled release of antiparasitic agents in animals |
| US5580578A (en) | 1992-01-27 | 1996-12-03 | Euro-Celtique, S.A. | Controlled release formulations coated with aqueous dispersions of acrylic polymers |
| DE4204151A1 (de) * | 1992-02-12 | 1993-08-19 | Schneider Manfred Prof Dr | Regioisomerenreine monoglyceride sowie ein verfahren zu ihrer herstellung durch enzymatische veresterung von glycerin in organischen loesungsmitteln |
| US5591767A (en) | 1993-01-25 | 1997-01-07 | Pharmetrix Corporation | Liquid reservoir transdermal patch for the administration of ketorolac |
| IT1270594B (it) | 1994-07-07 | 1997-05-07 | Recordati Chem Pharm | Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida |
| JPH0931020A (ja) * | 1995-07-25 | 1997-02-04 | Soda Koryo Kk | グリセロールモノ−６−ヒドロキシアルカン酸エステル、及びこれを含有する香料組成物 |
| SE9604582D0 (sv) * | 1996-12-13 | 1996-12-13 | Astra Ab | Novel compounds |
| JP4943612B2 (ja) * | 1999-11-18 | 2012-05-30 | エル ペダーソン リチャード | フェロモン又はその成分のメタセシス合成方法 |
| MY141736A (en) * | 2002-10-08 | 2010-06-15 | Elanco Animal Health Ireland | Substituted 1,4-di-piperidin-4-yi-piperazine derivatives and their use as neurokinin antagonists |
| JO2676B1 (en) * | 2004-04-06 | 2012-06-17 | جانسين فارماسوتيكا ان. في | Derivatives of second-aza-spiro- (5,4) -dikan and their use as antihistamines |
| CN1286529C (zh) * | 2004-06-11 | 2006-11-29 | 华中科技大学 | 具有皮肤靶向性的药物组合物及其制备方法和用途 |
| US7906147B2 (en) * | 2006-10-12 | 2011-03-15 | Nanoprobes, Inc. | Functional associative coatings for nanoparticles |
| MX2010007539A (es) * | 2008-01-11 | 2010-10-05 | United Paragon Associates Inc | Aislado de huevo fertilizado y uso del mismo. |
-
2010
- 2010-09-07 NZ NZ599215A patent/NZ599215A/en not_active IP Right Cessation
- 2010-09-07 RU RU2012112943/04A patent/RU2012112943A/ru not_active Application Discontinuation
- 2010-09-07 WO PCT/US2010/048006 patent/WO2011029099A1/en not_active Ceased
- 2010-09-07 AU AU2010289276A patent/AU2010289276A1/en not_active Abandoned
- 2010-09-07 KR KR1020127008768A patent/KR20120081120A/ko not_active Withdrawn
- 2010-09-07 CA CA2773035A patent/CA2773035A1/en not_active Abandoned
- 2010-09-07 US US13/394,067 patent/US20120190743A1/en not_active Abandoned
- 2010-09-07 CN CN2010800501768A patent/CN102740693A/zh active Pending
- 2010-09-07 MX MX2012002551A patent/MX2012002551A/es not_active Application Discontinuation
- 2010-09-07 SG SG2012015046A patent/SG178964A1/en unknown
- 2010-09-07 EP EP10814632.5A patent/EP2473038A4/en not_active Withdrawn
- 2010-09-07 JP JP2012528118A patent/JP2013503908A/ja active Pending
- 2010-09-07 BR BR112012004988A patent/BR112012004988A2/pt not_active Application Discontinuation
-
2012
- 2012-04-04 ZA ZA2012/02492A patent/ZA201202492B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2773035A1 (en) | 2011-03-10 |
| CN102740693A (zh) | 2012-10-17 |
| US20120190743A1 (en) | 2012-07-26 |
| WO2011029099A1 (en) | 2011-03-10 |
| EP2473038A1 (en) | 2012-07-11 |
| MX2012002551A (es) | 2012-09-07 |
| JP2013503908A (ja) | 2013-02-04 |
| BR112012004988A2 (pt) | 2015-09-08 |
| SG178964A1 (en) | 2012-04-27 |
| KR20120081120A (ko) | 2012-07-18 |
| ZA201202492B (en) | 2013-02-27 |
| EP2473038A4 (en) | 2013-10-23 |
| RU2012112943A (ru) | 2013-10-10 |
| AU2010289276A1 (en) | 2012-05-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TN2011000339A1 (en) | Poly (adp-ribose) polymerase (parp) inhibitors | |
| EA201590624A1 (ru) | Циклические эфиры пиразол-4-ил-гетероциклил-карбоксамидных соединений и способы их применения | |
| MX2012011533A (es) | Compuestos de pirazol-4-il-heterociclil-carboxamida y metodos de uso. | |
| MX2014005285A (es) | Compuestos biciclicos de piperazina. | |
| MY160349A (en) | Pyridone and aza-pyridone compounds and methods of use | |
| NZ597529A (en) | Oxazine derivatives and their use as bace inhibitors for the treatment of neurological disorders | |
| TW200738657A (en) | Thiazole compounds and methods of use | |
| MX355852B (es) | Compuestos de pirazolo [3,4-c] piridina y métodos de uso. | |
| PH12014500966A1 (en) | Alkylated piperazine compounds as inhibitors of btk activity | |
| MX2014005282A (es) | Compuestos de 8-fluoroftalazin-1 (2h) -ona. | |
| MX2011006006A (es) | Compuestos, composicion farmaceutica y metodos para utilizarse en el tratamiento de trastornos metabolicos. | |
| MX347917B (es) | Compuestos a base de imidazo[1,2-b]piridazina, composiciones que los comprenden, y metodos para su uso. | |
| PH12014500936A1 (en) | Heteroaryl pyridone and aza-pyridone compounds as inhibitors of btk activity | |
| NZ596836A (en) | NOVEL COMPOUND USEFUL FOR THE TREATMENT OF DEGENERATIVE AND INFLAMMATORY DISEASES; cyclopropanecarboxylic acid { 5-[4-(3,3-dimethyl-azetidine-1-carbonyl)-phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl} -amide | |
| EA201200373A1 (ru) | Соединения и композиции в качестве ингибиторов протеинкиназ | |
| EA201190158A1 (ru) | Производные бензофуранила для применения в качестве ингибиторов глюкокиназы | |
| MX2014014828A (es) | Compuestos de 5-azaindazol y metodos de uso. | |
| EA020330B3 (ru) | Хиназолиновые соединения | |
| CA2843514C (en) | (thieno[2,3-b][1,5]benzoxazepin-4-yl)piperazin-1-yl compounds as dual activity h1 inverse agonists/5-ht2a antagonists | |
| MX2012006822A (es) | 1,7-diazacarbazoles y metodos de uso. | |
| CY1111327T1 (el) | Υποκατεστημενα παραγωγα κυκλοεξυλοξεικου οξεος | |
| PL1891029T3 (pl) | Związki organiczne do leczenia stanów zapalnych lub alergicznych | |
| MX348024B (es) | Compuestos de adamantilo. | |
| MA32943B1 (fr) | Piperidine spiro pyrrolidione et piperidinone substituees, leur preparation et leur utilisation therapeutique | |
| EA201490630A1 (ru) | 6-замещенные 3-(хинолин-6-илтио)[1,2,4]триазоло[4,3-a]пиридины в качестве ингибиторов c-met тирозинкиназы |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| LAPS | Patent lapsed |